Compare PCT & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCT | NVCR |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Environmental Services | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | N/A | 2015 |
| Metric | PCT | NVCR |
|---|---|---|
| Price | $9.11 | $13.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | $13.67 | ★ $28.42 |
| AVG Volume (30 Days) | ★ 4.0M | 1.9M |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $5,660,000.00 | ★ $642,269,000.00 |
| Revenue This Year | N/A | $9.75 |
| Revenue Next Year | $707.73 | $5.62 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 11.17 |
| 52 Week Low | $5.40 | $10.70 |
| 52 Week High | $17.37 | $32.06 |
| Indicator | PCT | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 50.03 | 56.83 |
| Support Level | $7.43 | $12.30 |
| Resistance Level | $9.50 | $13.97 |
| Average True Range (ATR) | 0.61 | 0.57 |
| MACD | 0.16 | 0.08 |
| Stochastic Oscillator | 73.87 | 71.07 |
PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.